» Articles » PMID: 29465674

The Etiology of Vaginal Discharge Syndrome in Zimbabwe: Results from the Zimbabwe STI Etiology Study

Abstract

Introduction: Symptomatic vaginal discharge is a common gynecological condition managed syndromically in most developing countries. In Zimbabwe, women presenting with symptomatic vaginal discharge are treated with empirical regimens that commonly cover both sexually transmitted infections (STIs) and reproductive tract infections, typically including a combination of an intramuscular injection of kanamycin, and oral doxycycline and metronidazole regimens. This study was conducted to determine the current etiology of symptomatic vaginal discharge and assess adequacy of current syndromic management guidelines.

Methods: We enrolled 200 women with symptomatic vaginal discharge presenting at 6 STI clinics in Zimbabwe. Microscopy was used to detect bacterial vaginosis and yeast infection. Nucleic acid amplifications tests were used to detect Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, and Mycoplasma genitalium. In addition, serologic testing was performed to detect human immunodeficiency virus (HIV) infection.

Results: Of the 200 women, 146 (73%) had an etiology detected, including bacterial vaginosis (24.7%); N. gonorrhoeae (24.0%); yeast infection (20.7%); T. vaginalis (19.0%); C. trachomatis (14.0%) and M. genitalium (7.0%). Among women with STIs (N = 90), 62 (68.9%) had a single infection, 18 (20.0%) had a dual infection, and 10 (11.1%) had 3 infections.Of 158 women who consented to HIV testing, 64 (40.5%) were HIV infected.The syndromic management regimen covered 115 (57.5%) of the women in the sample who had gonorrhea, chlamydia, M. genitalium, or bacterial vaginosis, whereas 85 (42.5%) of women were treated without such diagnosis.

Conclusions: Among women presenting with symptomatic vaginal discharge, bacterial vaginosis was the most common etiology, and gonorrhea was the most frequently detected STI. The current syndromic management algorithm is suboptimal for coverage of women presenting with symptomatic vaginal discharge; addition of point of care testing could compliment the effectiveness of the syndromic approach.

Citing Articles

High Prevalence of Sexually Transmitted Infections and Poor Sensitivity and Specificity of Screening Algorithms for Chlamydia and Gonorrhea Among Female Sex Workers in Zimbabwe: Analysis of Respondent-Driven Sampling Surveys in 3 Communities.

Chabata S, Fearon E, Musemburi S, Machingura F, Machiha A, Hargreaves J Sex Transm Dis. 2025; 52(2):117-124.

PMID: 39774091 PMC: 11723496. DOI: 10.1097/OLQ.0000000000002086.


Prevalence of sexually transmitted infections (STIs), associations with sociodemographic and behavioural factors, and assessment of the syndromic management of vaginal discharge in women with urogenital complaints in Mozambique.

Manjate A, Sergon G, Kenga D, Golparian D, Tyulenev Y, Loquilha O Front Reprod Health. 2024; 6:1323926.

PMID: 38706519 PMC: 11067503. DOI: 10.3389/frph.2024.1323926.


Novel lateral flow assay for point-of-care detection of Neisseria gonorrhoeae infection in syndromic management settings: a cross-sectional performance evaluation.

Peters R, Klausner J, Mazzola L, Mdingi M, Jung H, Gigi R Lancet. 2024; 403(10427):657-664.

PMID: 38335982 PMC: 11246789. DOI: 10.1016/S0140-6736(23)02240-7.


Evaluation and optimization of the syndromic management of female genital tract infections in Nairobi, Kenya.

Omosa-Manyonyi G, de Kam M, Tostmann A, Masido M, Nyagah N, Obimbo M BMC Infect Dis. 2023; 23(1):547.

PMID: 37608250 PMC: 10463802. DOI: 10.1186/s12879-023-08442-2.


Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia.

Dunaiski C, Kock M, Jung H, Peters R Antimicrob Resist Infect Control. 2022; 11(1):104.

PMID: 35971143 PMC: 9377096. DOI: 10.1186/s13756-022-01143-6.


References
1.
Karou S, Djigma F, Sagna T, Nadembega C, Zeba M, Kabre A . Antimicrobial resistance of abnormal vaginal discharges microorganisms in Ouagadougou, Burkina Faso. Asian Pac J Trop Biomed. 2013; 2(4):294-7. PMC: 3609289. DOI: 10.1016/S2221-1691(12)60025-2. View

2.
Mhlongo S, Magooa P, Muller E, Nel N, Radebe F, Wasserman E . Etiology and STI/HIV coinfections among patients with urethral and vaginal discharge syndromes in South Africa. Sex Transm Dis. 2010; 37(9):566-70. DOI: 10.1097/OLQ.0b013e3181d877b7. View

3.
Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S . Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012; 367(5):411-22. PMC: 3687217. DOI: 10.1056/NEJMoa1202614. View

4.
Alam N, Chamot E, Vermund S, Streatfield K, Kristensen S . Partner notification for sexually transmitted infections in developing countries: a systematic review. BMC Public Health. 2010; 10:19. PMC: 2821362. DOI: 10.1186/1471-2458-10-19. View

5.
Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C . Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012; 206(1):6-14. PMC: 3490689. DOI: 10.1093/infdis/jis298. View